Epidemiology and clinical aspects of Adamantiades-Behçet disease in Gemany: Current data;Epidemiologie und Klinik des Morbus Adamantiades-Behçet in Deutschland Aktuelle Daten

Ophthalmologe

Volumn 109, Issue 6, 2012, Pages 531-541

  Altenburg, A ^a,b   Mahr, A ^c   Maldini, C ^c   Kneifel, C E ^a   Krause, L ^a,b   Kotter I ^b,d   Stache, T ^a   Bonitsis, N G ^a,b   Zouboulis, C C ^a,b  

^a DESSAU MEDICAL CENTER   (Germany)

^b Deutsches Register Morbus Adamantiades Behçet E v   (Germany)

^c SAINT LOUIS HOSPITAL   (France)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Adamantiades Beh et disease; Beh et disease; Germany; Initial manifestation; Prevalence

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BEHCET DISEASE; CHILD; ETHNOLOGY; FEMALE; GERMANY; HUMAN; MALE; MIDDLE AGED; PREVALENCE; REGISTER; RISK FACTOR; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BEHCET SYNDROME; CHILD; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; RISK FACTORS; TURKEY; YOUNG ADULT;

EID: 84862518261     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-012-2601-4     Document Type: Article

References (26)

1. Alli N, Gur G, Yalcin B, Hayran M (2009) Patient characteristics in Behçet disease: a retrospective analysis of 213 Turkish patients during 2001-4. Am J Clin Dermatol 10: 411-418.
2. Altenburg A, Papoutsis N, Orawa H et al (2006) Epidemiology and clinical manifestations of Adamantiades-Behçet disease in Germany - current pathogenetic concepts and therapeutic possibilities. J Dtsch Dermatol Ges 4: 49-64.
3. Appenzeller S, Castro R de, Queiroz Lde S et al (2006) Brain tumor-like lesion in Behçet disease. Rheumatol Int 26: 577-580.
4. Bang D, Yoon KH, Chung HG et al (1997) Epidemiological and clinical features of Behçet's disease in Korea. Yonsei Med J 38: 428-436.
5. Chung YM, Yeh TS, Sheu MM et al (1990) Behcet's disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments. J Formos Med Assoc 89: 413-417.
6. Davatchi F, Sadeghi Abdollahi B, Shahram F et al (2010) Validation of the International Criteria for Behçet's Disease (ICBD) in Iran. Int J Rheum Dis 13: 55-60.
7. Davatchi F, Shahram F, Chams-Davatchi C et al (2010) Behcet's disease in Iran: analysis of 6500 cases. Int J Rheum Dis 13: 367-373.
8. Geri G, Wechsler B, Thi Huong L et al (2012) Spectrum of cardiac lesions in Behçet disease: a series of 52 patients and review of the literature. Medicine (Baltimore) 91: 25-34.
9. Ideguchi H, Suda A, Takeno M et al (2010) Neurological manifestations of Behçet's disease in Japan: a study of 54 patients. J Neurol 257: 1012-1020.
10. International Study Group for Behcet's Disease (1990) Criteria for diagnosis of Behcet's disease. Lancet 335: 1078-1080.
11. Koçer N, Islak C, Siva A et al (1999) CNS involvement in neuro- Behçet-syndrome: an MR study. Am J Neuroradiol 20: 1015-1024.
12. Kötter I, Günaydin I, Batra M et al (2006) CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications - results of a retrospective analysis of 117 cases. Clin Rheumatol 25: 482-486.
13. Koné-Paut I, Yurdakul S, Bahabri SA et al (1998) Clinical features of Behçet's disease in children: an international collaborative study of 86 cases. J Pediatr 132: 721-725.
14. Krämer M, Baumgärtel MW, Neuen-Jacob E, Berlit P (2008) Myopathie beim Behçet-Syndrom. Z Rheumatol 67: 232-236.
15. Krause L (2005) Morbus Adamantiades-Behçet. Ophthalmologe 102: 329-334.
16. Krause L, Köhler AK, Altenburg A et al (2009) Ocular involvement in Adamantiades-Behçet's disease in Berlin, Germany. Graefes Arch Clin Exp Ophthalmol 247: 661-666.
17. Papoutsis NG, Abdel-Naser MB, Altenburg A et al (2006) Prevalence of Adamantiades-Behçet's disease in Germany and the municipality of Berlin: results of a nationwide survey. Clin Exp Rheumatol 25: 507-508.
18. Torres RM, Yanez B, Herreras JM, Calonge M (2004) Ocular Behcet disease. Retrospective study. Arch Soc Esp Oftalmol 79: 599-603.
19. Treudler R, Orfanos CE, Zouboulis CC (1999) Twenty-eight cases of juvenile-onset Adamantiades-Behçet disease in Germany. Dermatology 199: 15-19.
20. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R et al (2004) Uveitis in Behcet disease: an analysis of 880 patients. Am J Ophthalmol 138: 373-380.
21. Yoshida A, Kawashima H, Motoyama Y et al (2004) Comparison of patients with Behcet's disease in the 1980s and 1990s. Ophthalmology 111: 810-815.
22. Zierhut M, Saal J, Pleyer U et al (1995) Behcet's disease: epidemiology and eye manifestations in German and Mediterranean patients. Ger J Ophthalmol 4: 246-251.
23. Zouboulis CC (o J) Adamantiades-Behçet disease. In: Wolff K, Goldsmith LA, Katz SI et al (Hrsg) Fitzpatrick's dermatology in general medicine, 8. Aufl. McGraw Hill, New York (im Druck).
24. Zouboulis CC (1999) Epidemiology of Adamantiades-Behçet's disease. Ann Med Interne 150: 488-498.
25. Zouboulis CC (2003) Epidemiology of Adamantiades-Behçet's disease. In: Zierhut M, Ohno S (Hrsg) Immunology of Behçet's disease. Swets & Zeitlinger Publishers, Lisse, S 1-16.
26. Zouboulis CC, Keitel W (2002) A historical review of early descriptions of Adamantiades-Behçet's disease. J Invest Dermatol 119: 201-205.